IL15 and neoplasm: Xu et al. (2019) [261] studied the co-expression of G2D antigen-specific CAR and IL-15 in NKT cells both in vitro, and in immunodeficient mice with neuroblastoma xenografts, observing that both NKT in vivo persistence and tumor control were improved.